Publications

  1. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of Radioactive Iodine-Resistant Benign Struma Ovarii with Cervical Primary Papillary Cancer of the Thyroid: An Unusual Cause of Thyroglobulin-Positive Radioactive Iodine-Negative Whole-Body Scans. Thyroid. 2014 Jul 14.
    View PubMed
  2. Jrebi NY, Iqbal CW, Joliat GR, Sebo TJ, Farley DR. Review of Our Experience With Neuroblastoma and Ganglioneuroblastoma in Adults. World J Surg. 2014 Jul 08.
    View PubMed
  3. Sebo TJ. Erratum to: Thyroid nodules: team approach to a diagnostic and patient management challenge. Endocrine. 2014 Jun; 46(2):175.
    View PubMed
  4. Sebo TJ. Editorial review of ultrasound-guided fine-needle aspiration for solid thyroid nodules larger than 10 mm: correlation between sonographic characteristics at the needle tip and nondiagnostic results by Wu et al. Sebo review : Thyroid nodules: team approach to a diagnostic and patient management challenge. Endocrine. 2014 Jun; 46(2):173-4. Epub 2014 Jan 01.
    View PubMed
  5. Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H. p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis. Cancer Res. 2014 Mar 15; 74(6):1870-80. Epub 2014 Jan 30.
    View PubMed
  6. Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Cancer Cytopathol. 2014 Mar 6. [Epub ahead of print]
    View PubMed
  7. Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Mayo Clin Proc. 2014 Mar; 89(3):308-18. Epub 2014 Jan 31.
    View PubMed
  8. Law JH, Dean DS, Scheithauer B, Earnest F 4th, Sebo TJ, Fatourechi V. Symptomatic amyloid goiters: report of five cases. Thyroid. 2013 Nov; 23(11):1490-5. Epub 2013 Sep 19.
    View PubMed
  9. Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, Thiess M, Dy BM, Sebo TJ, Thompson GB, Grant CS, Giordano TJ, Gauger PG, Doherty GM, Fahey TJ 3rd, Bishop J, Eshleman JR, Umbricht CB, Schneider EB, Zeiger MA. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab. 2013 Sep; 98(9):3702-12. Epub 2013 Aug 22.
    View PubMed
  10. Alizad A, Mehrmohammadi M, Mitri FG, Davis BJ, Sebo TJ, Mynderse LA, Kinnick RR, Greenleaf JF, Fatemi M. Application of vibro-acoustography in prostate tissue imaging. Med Phys. 2013 Feb; 40(2):022902.
    View PubMed
  11. Brooks MD, Bennett RD, Weaver AL, Sebo TJ, Eckert SE, Strehler EE, Carr AB. Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation. Int J Dent. 2013; 2013:592843. Epub 2013 Jul 08.
    View PubMed
  12. Kurup AN, Thompson RH, Leibovich BC, Harmsen WS, Sebo TJ, Callstrom MR, Kawashima A, Atwell TD. Renal oncocytoma growth rates before intervention. BJU Int. 2012 Nov; 110(10):1444-8. Epub 2012 Apr 23.
    View PubMed
  13. Sebo TJ. What are the keys to successful thyroid FNA interpretation? Clin Endocrinol (Oxf). 2012 Jul; 77(1):13-7.
    View PubMed
  14. Bonin EA, Mariani A, Swain J, Bingener J, Sumiyama K, Knipschield M, Sebo TJ, Gostout CJ. Laparoscopic ultrasound-assisted liposuction for lymph node dissection: a pilot study. Surg Endosc. 2012 Jul; 26(7):1963-70. Epub 2012 Jan 19.
    View PubMed
  15. Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, Sebo TJ, Erdogan S, Rodriguez E, Murphy SJ, Vasmatzis G. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. Am J Pathol. 2012 Jul; 181(1):34-42. Epub 2012 May 26.
    View PubMed
  16. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, Algeciras-Schimnich A, Singh RJ, Dean DS. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012 Jul-Aug; 18(4):441-9.
    View PubMed
  17. Lima JF, Jin L, de Araujo AR, Erikson-Johnson MR, Oliveira AM, Sebo TJ, Keeney GL, Medeiros F. FOXL2 mutations in granulosa cell tumors occurring in males. Arch Pathol Lab Med. 2012 Jul; 136(7):825-8.
    View PubMed
  18. Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol Endocrinol. 2012 May; 26(5):716-35. Epub 2012 Mar 28.
    View PubMed
  19. Levy MJ, Oberg TN, Campion MB, Clayton AC, Halling KC, Henry MR, Kipp BR, Sebo TJ, Zhang J, Enders FT, Clain JE, Gleeson FC, Rajan E, Roberts LR, Topazian MD, Wang KK, Gores GJ. Comparison of methods to detect neoplasia in patients undergoing endoscopic ultrasound-guided fine-needle aspiration. Gastroenterology. 2012 May; 142(5):1112-1121.e2. Epub 2012 Feb 07.
    View PubMed
  20. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01.
    View PubMed
  21. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s.
    View PubMed
  22. Paner GP, Barkan GA, Mehta V, Sirintrapun SJ, Tsuzuki T, Sebo TJ, Jimenez RE. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol. 2012 Mar; 36(3):432-42.
    View PubMed
  23. Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, Bergen HR 3rd, Sebo TJ, Klee GG. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem. 2012 Mar; 58(3):599-609. Epub 2012 Jan 12.
    View PubMed
  24. Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V. Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid. 2011 Jul; 21(7):765-72. Epub 2011 May 13.
    View PubMed
  25. Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Zhang J. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR. Diagn Mol Pathol. 2011 Jun; 20(2):71-80.
    View PubMed
  26. Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol. 2011 Jun; 35(6):787-98.
    View PubMed
  27. Marlow LA, D'Innocenzi J, Zhang Y, Rohl SD, Cooper SJ, Sebo T, Grant C, McIver B, Kasperbauer JL, Wadsworth JT, Casler JD, Kennedy PW, Highsmith WE, Clark O, Milosevic D, Netzel B, Cradic K, Arora S, Beaudry C, Grebe SK, Silverberg ML, Azorsa DO, Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target. J Clin Endocrinol Metab. 2010 Dec; 95(12):5338-47. Epub 2010 Sep 01.
    View PubMed
  28. Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, Munz JM, Kosari F, Vasmatzis G. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. Cancer Res. 2010 Nov 15; 70(22):8994-9002. Epub 2010 Nov 09.
    View PubMed
  29. Henrichsen TL, Reading CC, Charboneau JW, Donovan DJ, Sebo TJ, Hay ID. Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas. J Clin Ultrasound. 2010 Sep; 38(7):361-6.
    View PubMed
  30. Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, Frank I. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology? BJU Int. 2010 Aug; 106(4):484-8. Epub 2010 Mar 01.
    View PubMed
  31. Summers HG, Loftus EV Jr, Sebo TJ, Durski JM. Appendiceal carcinoid mimicking a Meckel's diverticulum on Tc-99m pertechnetate imaging. Clin Nucl Med. 2010 Apr; 35(4):277-9.
    View PubMed
  32. Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010 Jan; 34(1):44-52.
    View PubMed
  33. Childs MA, Umbreit EC, Krambeck AE, Sebo TJ, Patterson DE, Gettman MT. Fibroepithelial polyps of the ureter: a single-institutional experience. J Endourol. 2009 Sep; 23(9):1415-9.
    View PubMed
  34. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol. 2009 Aug; 182(2):517-25; discussion 525-7. Epub 2009 Jun 13.
    View PubMed
  35. Fritcher EG, Kipp BR, Halling KC, Oberg TN, Bryant SC, Tarrell RF, Gores GJ, Levy MJ, Clayton AC, Sebo TJ, Roberts LR. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology. 2009 Jun; 136(7):2180-6. Epub 2009 Feb 14.
    View PubMed
  36. Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ. Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. Clin Cancer Res. 2009 Mar 15; 15(6):2174-80. Epub 2009 Mar 10.
    View PubMed
  37. Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer. 2009 Mar; 16(1):123-37. Epub 2008 Oct 09.
    View PubMed
  38. Kipp BR, Tanasescu M, Else TA, Bryant SC, Karnes RJ, Sebo TJ, Halling KC. Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer. J Mol Diagn. 2009 Mar; 11(2):148-54. Epub 2009 Jan 29.
    View PubMed
  39. Marlow LA, Reynolds LA, Cleland AS, Cooper SJ, Gumz ML, Kurakata S, Fujiwara K, Zhang Y, Sebo T, Grant C, McIver B, Wadsworth JT, Radisky DC, Smallridge RC, Copland JA. Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. Cancer Res. 2009 Feb 15; 69(4):1536-44. Epub 2009 Feb 10.
    View PubMed
  40. Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ, Blute ML. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol. 2009 Jan; 181(1):95-104; discussion 104. Epub 2008 Nov 13.
    View PubMed
  41. Brooks MD, Bennett RD, Strehler EE, Sebo TJ, Eckert SE, Carr AB. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. J Prosthodont. 2009 Jan; 18(1):11-6.
    View PubMed
  42. Humphreys MR, Castle EP, Lohse CM, Sebo TJ, Leslie KO, Andrews PE. Renal ischemia time in laparoscopic surgery: an experimental study in a porcine model. Int J Urol. 2009 Jan; 16(1):105-9.
    View PubMed
  43. Porterfield JR Jr, Grant CS, Dean DS, Thompson GB, Farley DR, Richards ML, Reading CC, Charboneau JW, Vollrath BK, Sebo TJ. Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery. 2008 Dec; 144(6):963-8; discussion 968-9.
    View PubMed
  44. Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol. 2008 Dec; 32(12):1877-89.
    View PubMed
  45. Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008 Dec; 144(6):980-7; discussion 987-8.
    View PubMed
  46. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. Outcomes following partial nephrectomy by tumor size. J Urol. 2008 Nov; 180(5):1912-7. Epub 2008 Sep 17.
    View PubMed
  47. Kipp BR, Tyner HL, Campion MB, Voss JS, Karnes RJ, Sebo TJ, Halling KC, Zhang J. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer. Am J Clin Pathol. 2008 Oct; 130(4):552-9.
    View PubMed
  48. Smoot RL, Zhang L, Sebo TJ, Que FG. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care. J Am Coll Surg. 2008 Sep; 207(3):368-70. Epub 2008 May 15.
    View PubMed
  49. Voss JS, Kipp BR, Krueger AK, Clayton AC, Halling KC, Karnes RJ, Henry MR, Sebo TJ. Changes in specimen preparation method may impact urine cytologic evaluation. Am J Clin Pathol. 2008 Sep; 130(3):428-33.
    View PubMed
  50. Fritcher EG, Brankley SM, Kipp BR, Voss JS, Campion MB, Morrison LE, Legator MS, Lutzke LS, Wang KK, Sebo TJ, Halling KC. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus. Hum Pathol. 2008 Aug; 39(8):1128-35. Epub 2008 Jul 07.
    View PubMed
  51. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008 May-Jun; 14(4):426-31.
    View PubMed
  52. Routh JC, Ashley RA, Sebo TJ, Lohse CM, Husmann DA, Kramer SA, Kwon ED. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. J Urol. 2008 May; 179(5):1954-9; discussion 1959-60. Epub 2008 Mar 20.
    View PubMed
  53. Levy MJ, Baron TH, Clayton AC, Enders FB, Gostout CJ, Halling KC, Kipp BR, Petersen BT, Roberts LR, Rumalla A, Sebo TJ, Topazian MD, Wiersema MJ, Gores GJ. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol. 2008 May; 103(5):1263-73.
    View PubMed
  54. Kipp BR, Halling KC, Campion MB, Wendel AJ, Karnes RJ, Zhang J, Sebo TJ. Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal. J Urol. 2008 Apr; 179(4):1296-301; discussion 1301. Epub 2008 Mar 04.
    View PubMed
  55. Magera JS Jr, Inman BA, Slezak JM, Bagniewski SM, Sebo TJ, Myers RP. Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy. J Urol. 2008 Jan; 179(1):130-5. Epub 2007 Nov 13.
    View PubMed
  56. Snozek CL, Chambers EP, Reading CC, Sebo TJ, Sistrunk JW, Singh RJ, Grebe SK. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab. 2007 Nov; 92(11):4278-81. Epub 2007 Aug 7.
    View PubMed
  57. Routh JC, Ashley RA, Sebo TJ, Vandersteen DR, Slezak J, Reinberg Y. Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux. J Urol. 2007 Oct; 178(4 Pt 2):1707-10. Epub 2007 Aug 17.
    View PubMed
  58. Sukov WR, Cheville JC, Lager DJ, Lewin JR, Sebo TJ, Lewin M. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors. Hum Pathol. 2007 Sep; 38(9):1432-7.
    View PubMed
  59. Levy MJ, Clain JE, Clayton A, Halling KC, Kipp BR, Rajan E, Roberts LR, Root RM, Sebo TJ, Topazian MD, Wang KK, Wiersema MJ, Gores GJ. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA. Gastrointest Endosc. 2007 Sep; 66(3):483-90.
    View PubMed
  60. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res. 2007 Aug 15; 67(16):7893-900. Epub 2007 Aug 08.
    View PubMed
  61. Barr Fritcher EG, Kipp BR, Slezak JM, Moreno-Luna LE, Gores GJ, Levy MJ, Roberts LR, Halling KC, Sebo TJ. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy. Am J Clin Pathol. 2007 Aug; 128(2):272-9.
    View PubMed
  62. Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007 May; 20(5):592-603. Epub 2007 Mar 30.
    View PubMed
  63. Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007 Apr 15; 109(8):1499-505.
    View PubMed
  64. Heemers HV, Sebo TJ, Debes JD, Regan KM, Raclaw KA, Murphy LM, Hobisch A, Culig Z, Tindall DJ. Androgen deprivation increases p300 expression in prostate cancer cells. Cancer Res. 2007 Apr 1; 67(7):3422-30.
    View PubMed
  65. Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15; 13(6):1749-56.
    View PubMed
  66. Fine SW, Argani P, DeMarzo AM, Delahunt B, Sebo TJ, Reuter VE, Epstein JI. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006 Dec; 30(12):1554-60.
    View PubMed
  67. Sengupta S, Davis BJ, Mynderse LA, Sebo TJ, Cheville JC, Lohse CM, Hillman DW, Haddock MG, Wilson TM. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy. Urology. 2006 Oct; 68(4):810-4.
    View PubMed
  68. Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, Barr Fritcher EG, Levy MJ, Gores GJ. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology. 2006 Oct; 131(4):1064-72. Epub 2006 Aug 16.
    View PubMed
  69. Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, Blute ML, Zincke H. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006 Sep; 68(3):604-8. Epub 2006 Sep 18.
    View PubMed
  70. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol. 2006 Sep; 15(3):136-43.
    View PubMed
  71. Humphreys MR, Ereth MH, Sebo TJ, Slezak JM, Dong Y, Blute ML, Gettman MT. Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbits. BJU Int. 2006 Sep; 98(3):674-9.
    View PubMed
  72. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006 Aug 15; 107(4):712-20.
    View PubMed
  73. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF Jr, Meyer FB, Kuroki T, Riehle DL, Laws ER Jr. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery. 2006 Aug; 59(2):341-53; discussion 341-53.
    View PubMed
  74. Sengupta S, Cheville JC, Lohse CM, Zincke H, Myers RP, Riehle DL, Pankratz VS, Blute ML, Sebo TJ. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. Urology. 2006 Jul; 68(1):94-8.
    View PubMed
  75. Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial. Am J Ther. 2006 Jul-Aug; 13(4):291-7.
    View PubMed
  76. Sengupta S, Slezak JM, Blute ML, Leibovich BC, Sebo TJ, Myers RP, Cheville JC, Bergstralh EJ, Zincke H. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
    View PubMed
  77. Krambeck AE, Dora CD, Sebo TJ, Rohlinger AL, DiMarco DS, Elliott DS. Time-dependent variations in inflammation and scar formation of six different pubovaginal sling materials in the rabbit model. Urology. 2006 May; 67(5):1105-10.
    View PubMed
  78. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006 Apr 1; 66(7):3381-5.
    View PubMed
  79. Pham TH, Sterioff S, Mullan BP, Wiseman GA, Sebo TJ, Grant CS. Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism. World J Surg. 2006 Mar; 30(3):327-32.
    View PubMed
  80. Mariani A, Sebo TJ, Cliby WA, Keeney GL, Riehle DL, Lesnick TG, Podratz KC. Role of bcl-2 in endometrioid corpus cancer: an experimental study. Anticancer Res. 2006 Mar-Apr; 26(2A):823-7.
    View PubMed
  81. Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V. Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid. 2006 Jan; 16(1):89-93.
    View PubMed
  82. Kipp BR, Sebo TJ, Griffin MD, Ihrke JM, Halling KC. Analysis of polyomavirus-infected renal transplant recipients' urine specimens: correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysis. Am J Clin Pathol. 2005 Dec; 124(6):854-61.
    View PubMed
  83. Kipp BR, Fritcher EG, del Rosario KM, Stevens CL, Sebo TJ, Halling KC. A systematic approach to identifying urothelial cells likely to be polysomic by fluorescence in situ hybridization. Anal Quant Cytol Histol. 2005 Dec; 27(6):317-22.
    View PubMed
  84. Reading CC, Charboneau JW, Hay ID, Sebo TJ. Sonography of thyroid nodules: a "classic pattern" diagnostic approach. Ultrasound Quarterly. 2005 Sep; 21(3):157-65.
    View PubMed
  85. Nakamura N, Carney JA, Jin L, Kajita S, Pallares J, Zhang H, Qian X, Sebo TJ, Erickson LA, Lloyd RV. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest. 2005 Sep; 85(9):1065-75.
    View PubMed
  86. Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Res. 2005 Jul-Aug; 25(4):2921-7.
    View PubMed
  87. Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI, Sebo TJ, Rosengart TK, Edwards WD, McCarthy PM, Bonow RO, Spelsberg TC. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation. 2005 Jun 21; 111(24):3296-301.
    View PubMed
  88. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
    View PubMed
  89. Ward JF, Sebo TJ, Blute ML, Zincke H. Salvage surgery for radiorecurrent prostate cancer: Contemporary outcomes. J Urol. 2005 Apr; 173(4):1156-60.
    View PubMed
  90. Mariani A, Sebo TJ, Katzmann JA, Roche PC, Keeney GL, Lesnick TG, Podratz KC. Endometrial cancer: can nodal status be predicted with curettage? Gynecol Oncol. 2005 Mar; 96(3):594-600.
    View PubMed
  91. Debes JD, Sebo TJ, Heemers HV, Kipp BR, Haugen DL, Lohse CM, Tindall DJ. p300 modulates nuclear morphology in prostate cancer. Cancer Res. 2005 Feb 1; 65(3):708-12.
    View PubMed
  92. Kipp BR, Karnes RJ, Brankley SM, Harwood AR, Pankratz VS, Sebo TJ, Blute MM, Lieber MM, Zincke H, Halling KC. Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization. J Urol. 2005 Feb; 173(2):401-4.
    View PubMed
  93. Sahin M, Allard BL, Yates M, Powell JG, Wang XL, Hay ID, Zhao Y, Goellner JR, Sebo TJ, Grebe SK, Eberhardt NL, McIver B. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab. 2005 Jan; 90(1):463-8. Epub 2004 Oct 13.
    View PubMed
  94. Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Cancer. 2004 Oct 15; 101(8):1803-8.
    View PubMed
  95. Sahin M, Allard BL, Yates M, Powell JG, Wang XL, Hay ID, Zhao Y, Goellner JR, Sebo TJ, Grebe SK, Eberhardt NL, McIver B. PPAR{gamma} staining as a surrogate for PAX8/PPAR{gamma} fusion oncogene expression in follicular neoplasms: clinico-pathologic correlation and histopathological diagnostic value. J Clin Endocrinol Metab. 2004 Oct 13.
    View PubMed
  96. Fang M, Lew E, Klein M, Sebo T, Su YY, Goyal R. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: Image cytometric DNA analysis in formalin-fixed tissues. Am J Gastroenterol. 2004 Oct; 99(10):1887-94.
    View PubMed
  97. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland identification through MIB-1 staining of fine-needle aspiration biopsy smears. Am J Clin Pathol. 2004 Oct; 122(4):506-10.
    View PubMed
  98. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JKC, DeLellis RA, Harach R, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004 Oct; 28(10):1336-40.
    View PubMed
  99. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004 Sep; 99(9):1675-81.
    View PubMed
  100. Rodriguez FJ, Abraham SC, Allen MS, Sebo TJ. Fine-needle aspiration cytology findings from a case of pancreatic heterotopia at the gastroesophageal junction. Diagn Cytopathol. 2004 Sep; 31(3):175-9.
    View PubMed
  101. Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol. 2004 Aug; 99(8):1464-9.
    View PubMed
  102. Aubry MC, Riehle DL, Edwards WD, Maradit-Kremers H, Roger VL, Sebo TJ, Gabriel SE. B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc Pathol. 2004 Jul-Aug; 13(4):233-6.
    View PubMed
  103. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland - Cytologic features in 29 cases. Am J Surg Pathol. 2004 Jul; 28(7):859-67.
    View PubMed
  104. Miller DV, McClure RF, Crawford BG, Zeldenrust SR, Leibovich BC, Sebo TJ. Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladder. Diagn Cytopathol. 2004 Jul; 31(1):48-51.
    View PubMed
  105. Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, Therneau TM, De Groen PC, Sebo TJ, Salomao DR, Kipp BR. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):214-9.
    View PubMed
  106. Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol. 2004 Feb; 121(2):220-5.
    View PubMed
  107. Ward JF, Bartsch G, Sebo TJ, Pinggera GM, Blute ML, Zincke H. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urologic Oncology. 2004 Jan-Feb; 22(1):40-7.
    View PubMed
  108. Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC, Jenkins RB. Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer. 2003 Nov 20; 107(4):580-2.
    View PubMed
  109. Debes JD, Sebo TJ, Lohse CM, Murphy LM, Haugen DL, Tindall DJ. p300 in prostate cancer proliferation and progression. Cancer Res. 2003 Nov 15; 63(22):7638-40.
    View PubMed
  110. DiMarco DS, Blute ML, Zincke H, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Sebo TJ. Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less. Urologic Oncology. 2003 Nov-Dec; 21(6):439-46.
    View PubMed
  111. Nagao T, Gaffey TA, Kay PA, Unni KK, Nascimento AG, Sebo TJ, Serizawa H, Minato H, Lewis JE. Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid gland. Hum Pathol. 2003 Oct; 34(10):1068-72.
    View PubMed
  112. Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H. Nephron-sparing surgery for renal cell carcinoma: Clinicopathologic features predictive of patient outcome. Urology. 2003 Oct; 62(4):641-6.
    View PubMed
  113. Isotalo PA, Keeney GL, Sebo TJ, Riehle DL, Cheville JC. Adenomatoid tumor of the adrenal gland - A clinicopathologic study of five cases and review of the literature. Am J Surg Pathol. 2003 Jul; 27(7):969-77.
    View PubMed
  114. D'Angelo MF, Kausik SJ, Sebo TJ, Rathbun SR, Kramer SA, Husmann DA. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression. J Urol. 2003 May; 169(5):1815-7.
    View PubMed
  115. Gaffney RL, Carney JA, Sebo TJ, Erickson LA, Volante M, Papotti M, Lloyd RV. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol. 2003 Apr; 27(4):494-8.
    View PubMed
  116. Garrity MM, Burgart LJ, Riehle DL, Hill EM, Sebo TJ, Witzig T. Identifying and quantifying apoptosis: Navigating technical pitfalls. Mod Pathol. 2003 Apr; 16(4):389-94.
    View PubMed
  117. Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer. 2003 Jan 1; 97(1):1-11.
    View PubMed
  118. Dechet CB, Zincke H, Sebo TJ, King BF, LeRoy AJ, Farrow GM, Blute ML. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol. 2003 Jan; 169(1):71-4.
    View PubMed
  119. Mariani A, Sebo TJ, Webb MJ, Riehle D, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detect Prev. 2003; 27(6):434-41.
    View PubMed
  120. Adem C, Sebo TJ, Riehle DL, Lohse CM, Nascimento AG. Recurrent and non-recurrent pigmented villonodular synovitis - A comparison of clinical and pathologic findings including DNA ploidy and proliferation by digital image analysis. Ann Pathol. 2002 Dec; 22(6):448-52.
    View PubMed
  121. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology. 2002 Oct; 123(4):1323-30.
    View PubMed
  122. Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002 Sep 15; 95(6):1215-9.
    View PubMed
  123. Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML. Metastatic prostate carcinoma to bone - Clinical and pathologic features associated with cancer-specific survival. Cancer. 2002 Sep 1; 95(5):1028-36.
    View PubMed
  124. Kuriyama H, Lamborn KR, O'Fallon JR, Iturria N, Sebo T, Schaefer PL, Scheithauer BW, Buckner JC, Kuriyama N, Jenkins RB, Israel MA. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro Oncol. 2002 Jul; 4(3):179-86.
    View PubMed
  125. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002 Jun 4; 105(22):2660-5.
    View PubMed
  126. Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol. 2002 May; 167(5):2001-6.
    View PubMed
  127. Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cancer. 2002 Apr 15; 94(8):2180-4.
    View PubMed
  128. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, Blute ML, Zincke H. Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer. Am J Surg Pathol. 2002 Apr; 26(4):431-9.
    View PubMed
  129. Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol. 2002 Mar; 26(3):292-300.
    View PubMed
  130. Kay PA, Riehle DL, Cheville JC, Lohse CM, Pankratz VS, Hill EM, Sebo TJ. Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinoma. Anal Quant Cytol Histol. 2002 Feb; 24(1):7-14.
    View PubMed
  131. Gaffey TA, Scheithauer BW, Lloyd RV, Burger PC, Robbins P, Fereidooni F, Horvath E, Kovacs K, Kuroki T, Young WF Jr, Sebo TJ, Riehle DL, Belzberg AJ. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg. 2002 Feb; 96(2):352-60.
    View PubMed
  132. Erickson LA, Jin L, Sebo TJ, Lohse C, Pankratz VS, Kendrick ML, van Heerden JA, Thompson GB, Grant CS, Lloyd RV. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms. Endocr Pathol. 2001 Winter; 12(4):429-35.
    View PubMed
  133. Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol. 2001 Nov; 166(5):1692-7.
    View PubMed
  134. Rajamannan NM, Caplice N, Anthikad F, Sebo TJ, Orszulak TA, Edwards WD, Tajik J, Schwartz RS. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects. J Heart Valve Dis. 2001 Nov; 10(6):827-31.
    View PubMed
  135. So MJ, Cheville JC, Katzmann JA, Riehle DL, Lohse CM, Pankratz VS, Sebo TJ. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry. Mod Pathol. 2001 Sep; 14(9):906-12.
    View PubMed
  136. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, Blute ML, Zincke H. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer. 2001 Jun 1; 91(11):2196-204.
    View PubMed
  137. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001 Jun; 32(6):596-604.
    View PubMed
  138. Wahner-Roedler DL, Sebo TJ, Gisvold JJ. Hamartomas of the breast: clinical, radiologic, and pathologic manifestations. Breast J. 2001 Mar-Apr; 7(2):101-5.
    View PubMed
  139. McClure RF, Keeney GL, Sebo TJ, Cheville JC. Serous borderline tumor of the paratestis: a report of seven cases. Am J Surg Pathol. 2001 Mar; 25(3):373-8.
    View PubMed
  140. Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc. 2001 Jan; 76(1):29-33.
    View PubMed
  141. Krueger WR, Fletcher JG, Sebo TJ. Radiological case of the month. Appl Radiol. 2001; 30(10):44-6.
    View PubMed
  142. Tirzaman O, Wahner-Roedler DL, Malek RS, Sebo TJ, Li CY, Kyle RA. Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Mayo Clin Proc. 2000 Dec; 75(12):1264-8.
    View PubMed
  143. Stefaneanu L, Kovacs K, Scheithauer BW, Kontogeorgos G, Riehle DL, Sebo TJ, Murray D, Vidal S, Tran A, Buchfelder M, Fahlbusch R. Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr Pathol. 2000 Win; 11(4):341-352.
    View PubMed
  144. Leibovich BC, Blute ML, Bostwick DG, Wilson TM, Pisansky TM, Davis BJ, Ramnani DM, Cheng L, Sebo TJ, Zincke H. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology. 2000 Nov 1; 56(5):726-9.
    View PubMed
  145. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000 Nov; 164(5):1768-75.
    View PubMed
  146. Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology. 2000 Sep; 119(3):624-30.
    View PubMed
  147. Chang HJ, Batts KP, Lloyd RV, Sebo TJ, Thompson GB, Lohse CM, Pankratz SV. Prognostic significance of p27, Ki-67, and topoisomerase II alpha expression in clinically nonfunctioning pancreatic endocrine tumors. Endocr Pathol. 2000 Fall; 11(3):229-241.
    View PubMed
  148. Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000 Aug; 13(8):900-8.
    View PubMed
  149. Lazcano O, Chen LM, Tsai C, Li CY, Katzmann JA, Sebo TJ, Kimlinger TK, Baker J. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions. Mod Pathol. 2000 Jul; 13(7):788-96.
    View PubMed
  150. Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol. 2000 Jun; 182(6):1535-44.
    View PubMed
  151. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Nehra A, Malek RS, Zincke H, Bostwick DG. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer. 2000 Apr 1; 88(7):1679-86.
    View PubMed
  152. Cheng L, Cheville JC, Sebo TJ, Eble JN, Bostwick DG. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer. 2000 Feb 15; 88(4):853-61.
    View PubMed
  153. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer. 2000 Feb 15; 88(4):844-52.
    View PubMed
  154. Cheville JC, Wu K, Sebo TJ, Cheng L, Riehle D, Lohse CM, Shane V. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma? Cancer. 2000 Feb 1; 88(3):632-6.
    View PubMed
  155. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol. 2000 Jan; 163(1):174-8.
    View PubMed
  156. Itano NB, Lightner DJ, Brandt KR, Sebo TJ. Xanthogranulomatous urethritis: a case report. Journal of Pelvic Surgery. 2000; 6(5):284-5.
    View PubMed
  157. Perry A, Jenkins R, O'Fallon J, Buckner J, Schaefer P, Kimmel D, Mahoney M, Scheithauer B, Smith S, Hill E, Sebo T, Levitt R, Krook J, Tschetter L, Morton R Clinicopathologic Study of 85 Uniformly Treated Anaplastic Astrocytic Tumors: an Analysis of DNA Content (Ploidy), Cellular Proleferation, and p53 Expression Cancer. 2000; 89:1699-1705.
    View PubMed
  158. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999 Oct; 162(4):1282-4; discussion 1284-5.
    View PubMed
  159. Cheng L, Pisansky TM, Sebo TJ, Leibovich BC, Ramnani DM, Weaver AL, Scherer BG, Blute ML, Zincke H, Bostwick DG. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res. 1999 Oct; 5(10):2820-3.
    View PubMed
  160. Perry A, Jenkins RB, O'Fallon JR, Schaefer PL, Kimmel DW, Mahoney MR, Scheithauer BW, Smith SM, Hill EM, Sebo TJ, Levitt R, Krook J, Tschetter LK, Morton RF, Buckner JC. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression. Cancer. 1999 Aug 15; 86(4):672-83.
    View PubMed
  161. Cheng L, Cheville JC, Pisansky TM, Sebo TJ, Slezak J, Bergstralh EJ, Neumann RM, Singh R, Pacelli A, Zincke H, Bostwick DG. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999 Jul; 23(7):803-8.
    View PubMed
  162. Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, Pacelli A, Neumann RM, Zincke H, Bostwick DG. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer. 1999 Mar 15; 85(6):1293-9.
    View PubMed
  163. Corica FA, Iczkowski KA, Cheng L, Zincke H, Blute ML, Wendel A, Sebo TJ, Neumann R, Bostwick DG. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol. 1999 Feb; 161(2):408-11.
    View PubMed
  164. Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, Forsyth PA, Hayostek CJ. Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol. 1999 Jan; 58(1):46-53.
    View PubMed
  165. Perry A, Jenkins R, O'Fallon J, Schaefer P, Kimmel D, Mahoney M, Scheithauer B, Smith S, Hill E, Sebo T, Levitt R, Krook J, Tschetter L, Morton R, Buckner J Clinicopathologic study of 85 uniformly treated anaplastic astrocytic tumors: An analysis of DNA content (ploidy), cellular proliferation, and p53 expression Cancer. 1999; 86:672-83.
    View PubMed
  166. Cheng L, Sebo TJ, Slezak J, Pisansky TM, Bergstralh EJ, Neumann RM, Iczkowski KA, Zincke H, Bostwick DG. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998 Nov 15; 83(10):2164-71.
    View PubMed
  167. Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol. 1998 Nov; 22(11):1361-7.
    View PubMed
  168. Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P. Expression of p27kip1 in prostatic adenocarcinoma. Mod Pathol. 1998 Apr; 11(4):324-8.
    View PubMed
  169. Cheville JC, Dundore PA, Bostwick DG, Lieber MM, Batts KP, Sebo TJ, Farrow GM. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer. 1998 Feb 15; 82(4):703-7.
    View PubMed
  170. Cheville J, Lloyd R, Sebo T, Cheng L, Erickson L, Bostwick D, Lohse C, Wollan P Expression of p27(kip1) in prostatic adenocarcinoma. Mod Pathol. 1998; 11(4):324-328.
    View PubMed
  171. Lloyd RV, Ferreiro JA, Jin L, Sebo TJ. TGFB, TGFB Receptors, Ki-67, and p27(Kip)l Expression in Papillary Thyroid Carcinomas. Endocr Pathol. 1997 Winter; 8(4):293-300.
    View PubMed
  172. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 Oct; 113(4):1074-81.
    View PubMed
  173. Wahner-Roedler DL, Sebo TJ. Renal cell carcinoma: diagnosis based on metastatic manifestations. Mayo Clin Proc. 1997 Oct; 72(10):935-41.
    View PubMed
  174. Payne PW, Sebo TJ, Doudkine A, Garner D, MacAulay C, Lam S, LeRichie JC, Palcic B. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc. 1997 Aug; 72(8):697-704.
    View PubMed
  175. Lewis JE, Olsen KD, Sebo TJ. Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol. 1997 Jun; 28(6):664-73.
    View PubMed
  176. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF Jr, Lloyd RV, Davis DH, Guthrie BL, Schoene WC. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. 1997 Feb 15; 79(4):804-12.
    View PubMed
  177. Brown JA, Sebo TJ, Segura JW. Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain. Urology. 1996 Sep; 48(3):473-5.
    View PubMed
  178. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol. 1996 Aug; 62(2):192-8.
    View PubMed
  179. Voneschenbach AC, Brawer MK, Disantagnese PA, Humphrey PA, Mahran H, Murphy GP, Sebo TJ, Veltri R. Workgroup Four: exploration of new pathologic factors in terms of potential for prognostic significance and future applications. Cancer. 1996 Jul 15; 78(2):372-375.
    View PubMed
  180. Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, Scardino PT, Humphrey PA, Hudson MA, Fradet Y, Miller GJ, Crawford ED, Blumenstein BA, Mahran HE, Miles BJ. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology. 1996 Jul; 48(1):47-57.
    View PubMed
  181. Sebo TJ. DNA content analysis of prostate cancer in needle biopsies. Pathol Case Rev. 1996; 1(2):84-9.
  182. Sebo TJ. Digital image analysis. Mayo Clin Proc. 1995 Jan; 70(1):81-2.
    View PubMed
  183. Sebo TJ, Bostwick DG, Farrow GM, Eble JN. Prostatic xanthoma: a mimic of prostatic adenocarcinoma. Hum Pathol. 1994 Apr; 25(4):386-9.
    View PubMed
  184. Yale SH, Adlakha A, Sebo TJ, Ryu JH. Bronchiolitis obliterans organizing pneumonia caused by Plasmodium vivax malaria. Chest. 1993 Oct; 104(4):1294-6.
    View PubMed
  185. Sebo TJ, Roche PC, Witzig TE, Kurtin PJ. Proliferative activity in non-Hodgkin's lymphomas. A comparison of the bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis. Am J Clin Pathol. 1993 Jun; 99(6):668-72.
    View PubMed
  186. Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival. Gynecol Oncol. 1992 Nov; 47(2):191-5.
    View PubMed
  187. Sebo TJ. Tumor biology and the surgical pathologist. Journal of Insurance Medicine (Seattle) 1992 Spring; 24(1):69-74.
    View PubMed
  188. O'Donnell AE, Mappin FG, Sebo TJ, Tazelaar H. Interstitial pneumonitis associated with "crack" cocaine abuse. Chest. 1991 Oct; 100(4):1155-7.
    View PubMed
  189. Dunaway GA, Kasten TP, Sebo TJ, Trapp R. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem J. 1988; 251:677-83.
    View PubMed
  190. Sebo TJ, Schmit JC. Analytical gel electrophoresis of high-molecular-weight RNA in acrylamide-agarose gels containing methylmercuric hydroxide. Anal Biochem. 1982 Feb; 120(1):136-45.
    View PubMed
  191. Sebo TJ, Schmit JC. A convenient method for the storage and cultivation of spheroplasts of Neurospora crassa. Neurospora Newsletter. 1980; 27:30.